Amicus Therapeutics, Inc.

Amicus Therapeutics is a global, patient-dedicated biotechnology company with its global headquarters in Princeton. It is focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease.